Physician profile
Sudha S Tallavajhula
NPI 1851595441
$13,914.22
in general payments reported to CMS, 2019-2025
14 companies · $2,429 in 2025
The $2,429 reported for 2025 was more than what 78% of Clinical Neurophysiology providers received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2022: $5,198 · 2023: $4,758 · 2024: $1,263 · 2025: $2,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,850 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,500 · Food and Beverage: $1,269 · Honoraria: $750 · Education: $54.99 · Travel and Lodging: $25.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,850.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,500.00 |
| Food and Beverage | $1,269.22 |
| Honoraria | $750.00 |
| Education | $54.99 |
| Travel and Lodging | $25.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $12,301.29 | 2022-2025 | Remede System |
| Jazz Pharmaceuticals INC. | $676.38 | 2019-2025 | |
| Harmony Biosciences LLC | $219.72 | 2022-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $184.53 | 2023-2025 | Lumryz |
| Sumitomo Pharma America, INC. | $132.18 | 2023 | Aptiom |
| Inspire Medical Systems, INC. | $110.21 | 2019 | |
| Axsome Therapeutics, INC. | $58.58 | 2024 | Sunosi |
| Argenx US, INC. | $56.67 | 2023-2024 | Vyvgart Hytrulo, Vyvgart |
| Ucb, INC. | $55.87 | 2019-2025 | Rystiggo |
| Eisai INC. | $35.23 | 2022 | |
| Sk Life Science, INC. | $31.89 | 2023 | |
| Otter Pharmaceuticals, LLC | $24.94 | 2024 | Sympazan |
| Acadia Pharmaceuticals INC | $24.25 | 2023 | Daybue |
| Aucta Pharmaceuticals, INC. | $2.48 | 2024 | Motpoly Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sudha Tallavajhula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.